NDC 17856-0353-2 - Pharbetol Regular strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0353
- Requested NDC
- 17856-0353-2
- Package NDCs from labels
- 17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHARBEST IBUPROFEN Drug Facts | ATLANTIC BIOLOGICALS CORP. | 2025-06-05 | HUMAN OTC DRUG LABEL |
| Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-04-30 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| pain relief extra strength | ACETAMINOPHEN | HyVee Inc | 1e707628-08b1-4c72-b71c-2b4ae96071f2 | 2026-02-06 | Warnings | M013 362O9ITL9D |
| CareOne Acetaminophen PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | American Sales Company | 2d2ded37-f241-4976-886d-5c038a85bfe1 | 2026-02-05 | Warnings | M013 362O9ITL9D |
| Dolex Fem | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Pharmadel LLC | b1cab10b-19f1-f5d5-e053-2995a90a4d5f | 2026-02-05 | Warnings | M013 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | KVK-Tech, Inc. | f1063950-b302-4898-81c2-b1626c9c16ef | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Alka-Seltzer Extra Strength Pain Relief | ANHYDROUS CITRIC ACID, ASPIRIN | Bayer HealthCare LLC. | 4a16b6e5-f0c6-e3a4-e063-6294a90a85ad | 2026-02-05 | Warnings | M013 |
| Hydrocodone/APAP | HYDROCODONE/APAP | Direct_Rx | 446e9f78-4034-5bb4-e063-6394a90ac739 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Hydrocodone/APAP | HYDROCODONE/APAP | Direct_Rx | 446f01f0-2853-d104-e063-6394a90ae351 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Cold and Flu plus Congestion Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | WALMART INC. | 52a398eb-e593-458b-9c42-6f653ca391be | 2026-02-04 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | American Health Packaging | 88e5345a-f240-473c-b329-2b0aa5f081f9 | 2026-02-04 | Warnings | 362O9ITL9D |
| Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 85aadc86-d979-41a1-849a-e2ccc9014429 | 2026-02-04 | Warnings | 362O9ITL9D |
| severe cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDE | HyVee Inc | fa8c154c-56c6-47de-8e43-9e012b4be95f | 2026-02-04 | Warnings | 362O9ITL9D |
| Pain Relief childrens | ACETAMINOPHEN | CVS PHARMACY | b8ab85a6-3eab-4ef4-a13d-5ac300480f63 | 2026-02-03 | Warnings | M013 362O9ITL9D |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Discount Drug Mart | ba64c29d-4a50-47b7-be6b-6cf7db11a97a | 2026-02-03 | Warnings | 362O9ITL9D |
| Motrin Dual Action With Tylenol | ACETAMINOPHEN AND IBUPROFEN | Kenvue Brands LLC | f2ee9cf5-02b7-6612-e053-2995a90a90c4 | 2026-02-03 | Warnings | 362O9ITL9D |
| Daytime Cold and Flu Mini Softgels | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Shield Pharmaceuticals Corp | 63cb19d4-2306-4723-a95e-9d2d8b9eccd0 | 2026-02-03 | Warnings | 362O9ITL9D |
| MINIDROPS | LUBRICANT EYE DROPS | Optics Laboratory, Inc | c13c5f91-50df-471c-a7c9-1747a2ac1250 | 2026-02-03 | Warnings | FZ989GH94E |
| Nighttime Cold and Flu Mini Softgels | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Shield Pharmaceuticals Corp | b9af8ab4-a7cb-4adf-9f6f-398c6bb7f853 | 2026-02-03 | Warnings | 362O9ITL9D |
| severe cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | HyVee Inc | 987f908b-7af7-4705-bfb4-c48d771c380d | 2026-02-03 | Warnings | 362O9ITL9D |
| basic care aspirin | ASPIRIN | Amazon.com Services LLC | 265c7d85-a666-4234-9c30-ca8e31f4bcb8 | 2026-02-03 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Hikma Pharmaceuticals USA Inc. | 7243bf2c-2c44-4dff-8a9e-d788d31dca86 | 2026-02-03 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.